» Articles » PMID: 22865704

The Medial Habenula Contains a Specific Nonstellate Subtype of Astrocyte Expressing the Ectonucleotidase NTPDase2

Overview
Journal Glia
Specialty Neurology
Date 2012 Aug 7
PMID 22865704
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

ATP-mediated synaptic transmission represents the only transmitter-gated Ca(2+)-entry pathway in neurons of the rodent medial habenula. In addition to direct purinergic receptor-mediated synaptic inputs, the medial habenula contains purinergic systems that modulate synaptic transmission. Purinergic signaling is modulated or terminated by ectonucleotidase, nucleotide-hydrolyzing enzymes of the cell surface. Here we identify the major ectonucleotidase responsible for the hydrolysis of extracellular ATP in the mouse medial habenula as ectonucleoside triphosphate diphosphohydrolase 2 (NTPDase2), using immunostaining and enzyme histochemistry. Double labeling experiments reveal that the enzyme is expressed by astrocytes enwrapping the densely packed neurons and also the myelinated fiber bundles of the stria medullaris. NTPDase2 immunoreactivity is absent from the lateral habenula. The analysis of mice expressing enhanced green fluorescent protein under the promoter of glial fibrillary acidic protein revealed that the medial habenula harbors a highly polar type of astrocytes with very long laminar cellular processes, untypical for grey matter astrocytes. Its morphology strongly differs from that of the stellate astrocytes in the adjacent lateral habenula. Our results suggest that the mouse medial habenula contains a specific perineuronal nonstellate subtype of astrocyte that expresses the ectonucleotidase NTPDase2 and is in a strategic position to modulate purinergic transmission in this subnucleus.

Citing Articles

Extracellular Purine Metabolism-Potential Target in Multiple Sclerosis.

Laketa D, Lavrnja I Mol Neurobiol. 2024; 61(10):8361-8386.

PMID: 38499905 DOI: 10.1007/s12035-024-04104-9.


Expression of Ectonucleoside Triphosphate Diphosphohydrolase 2 (NTPDase2) Is Negatively Regulated Under Neuroinflammatory Conditions and .

Dragic M, Mihajlovic K, Adzic M, Jakovljevic M, Zaric Kontic M, Mitrovic N ASN Neuro. 2022; 14:17590914221102068.

PMID: 35593054 PMC: 9125070. DOI: 10.1177/17590914221102068.


Enzyme histochemistry: a useful tool for examining the spatial distribution of brain ectonucleotidases in (patho)physiological conditions.

Grkovic I, Mitrovic N, Dragic M, Zaric Kontic M Histol Histopathol. 2022; 37(10):919-936.

PMID: 35575291 DOI: 10.14670/HH-18-471.


Development of Anthraquinone Derivatives as Ectonucleoside Triphosphate Diphosphohydrolase (NTPDase) Inhibitors With Selectivity for NTPDase2 and NTPDase3.

Baqi Y, Rashed M, Schakel L, Malik E, Pelletier J, Sevigny J Front Pharmacol. 2020; 11:1282.

PMID: 32973513 PMC: 7481482. DOI: 10.3389/fphar.2020.01282.


Three-Dimensional Analysis of Mouse Habenula Subnuclei Reveals Reduced Volume and Gene Expression in the Lipopolysaccharide-mediated Depression Model.

Yang E, Kim J, Yang S, Lee E, Sun W, Lee H Exp Neurobiol. 2020; 28(6):709-719.

PMID: 31902158 PMC: 6946114. DOI: 10.5607/en.2019.28.6.709.